BORGESON BLAKE sold 3.2% of their position (220K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $959.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/8/2026ACC: 0001856094-26-000002
Director
Since Apr 2021
-220K
Net shares
Net seller
$959.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
220K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−220K
Price / share
$4.36
Trade value
$959.20K
% of position
3.2%
1/6/2026
6.87M→6.65M
Total
Net shares
−220K
Net value
-$959.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 1/6/2026 | S · Sale | −220K | $4.36 | $959.20K | 3.2% | 6.87M | 6.65M |
| Total | −220K | -$959.20K | ||||||
Derivative Transactions0
No derivative transactions reported